News, stories and opinions for the business innovators of the world.

World first imaging incubator uses unconventional approach to monitor embryos

Roger LangsdonMarketing Director

Genea Biomedx has created an incubation instrument with time lapse photography, which allows scientists and potential parents to watch their embryos grow in their first crucial few days.

There are over 1.5 million IVF cycles a year helping people fulfill their dream of having a family. One of the challenges of IVF is the need for embryologists to remove embryos from the incubator to review them under the microscope, taking them out of the ideal growth conditions for short periods of time.

Genea Biomedx asked the simple question: What if we could integrate a low-cost imaging solution within the incubator itself, thereby eliminating the need to remove the embryo from its safe environment for grading? The answer to this challenge would not lie in conventional IVF technology.

Working with Planet Innovation, Genea Biomedx bucked the market trend of developing a bigger, more expensive microscope. Instead, it looked beyond the medical industry and discovered a low cost imaging system that could achieve an image quality suitable for embryologists to assess key embryo features.

The imaging incubator, known as Geri, is different to other incubators on the market in that it combines a low-cost multi-camera imaging system with individually controlled multi-patient incubator chambers. This means that embryologist can assess an embryo’s development by observing high-quality time-lapse images while the embryo remains safely contained within the regulated environment of an embryonic incubator. All this was made possible through the unorthodox approach of integrating high quality camera technology from non-medical industries.


Update: National broadcaster, 7 News, reported on the story here.

SHARE THIS ARTICLE:
Roger Langsdon Marketing Director
Roger Langsdon

Roger is the Marketing Director at Planet Innovation and a specialist marketing and communications professional with a focus on growing an organization’s reputation and revenue through strategic marketing and high-impact communications.

Roger Langsdon

Related Articles.

Atmo Biosciences and Seed Health announce research partnership to evaluate impact of probiotics on gut microbiome

News

Seed Health, a US-based microbial sciences company, and Atmo Biosciences, a Planet Innovation early stage venture, have announced a partnership to use Atmo’s ingestible gas-sensing capsule to study the impact of probiotics on the gut microbiome.

Tackling the global health threat of antibiotic resistance through Lumos Diagnostics and the FebriDx test

Diagnostics

November 18-24 is World Antibiotic Awareness Week, so it’s a good time to draw attention to the global health challenge of antibiotic resistance, which Planet Innovation is combating through its business Lumos Diagnostics.

IDEX Health & Science launches Tridex™ Protein Analyzer for bioprocessing

Life Sciences

IDEX Health & Science has launched the Tridex™ Protein Analyzer, which Planet Innovation helped develop, to measure protein titer directly from a bioreactor in real time.

The EU Medical Device Regulations (EU 2017/745) in a nutshell

Manufacturing

With the European Medical Device Regulations deadline looming, we look at the major changes impacting medical device manufacturers and the release of a few guidance documents by the European Commission.

News

Atmo Biosciences and Seed Health announce research partnership to evaluate impact of probiotics on gut microbiome

Seed Health, a US-based microbial sciences company, and Atmo Biosciences, a Planet Innovation early stage venture, have announced a partnership to use Atmo’s ingestible gas-sensing capsule to study the impact of probiotics on the gut microbiome.